SEC Form 4 · accession 0001179110-18-003976
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jared Watkin
Officer — Senior Vice President
Period of report
Mar 7, 2018
Accepted (ET)
Mar 9, 2018 · 5:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Mar 7, 2018 | S | 300 | $61.19 | D | 68,215 | D | |
| Common shares without par value | Mar 7, 2018 | S | 400 | $61.191 | D | 67,815 | D | |
| Common shares without par value | Mar 7, 2018 | S | 1,573 | $61.193 | D | 66,242 | D | |
| Common shares without par value | Mar 7, 2018 | S | 727 | $61.195 | D | 65,515 | D | |
| Common shares without par valueF1 | holding | — | — | — | 494 | I | Profit Sharing Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Balance in the Abbott Laboratories Stock Retirement Trust as of March 7, 2018.